Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.284
https://www.valueinhealthjournal.com/article/S1098-3015(16)30864-6/fulltext
Title :
Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30864-6&doi=10.1016/j.jval.2016.08.284
First page :
A885
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2715